Navigation Links
Medical Device Consultants, Inc. and Clinical Development & Support Services Ltd Announce Strategic Partnership

NORTH ATTLEBORO, Mass., July 20 /PRNewswire/ -- Medical Device Consultants, Inc. (MDCI), a full-service regulatory consulting and contract research organization (CRO) serving the medical device and diagnostics industry, today announced a strategic partnership with Clinical Development & Support Services Ltd (CDSS), a clinical services and CRO based in Cheshire, England.  This relationship will allow clients access to the best of both organizations' core strengths and geographical expertise.  The service expansion will be accomplished through mutual referrals, coordinated sales, marketing, and presentation activities.

Leslie Rose, Director of Clinical Services at MDCI said, "Our primary aim is to fully support clients as they design and conduct medical device and IVD clinical trials both in the US and Europe. The CDSS network of employee and contract clinical research professionals in the UK and across Europe complements MDCI's full service CRO activities.  This collaboration of two former competitors combines our strengths to provide broader and deeper clinical and regulatory solutions for all of our medical device clients."

John Illingworth, Manager Director at CDSS said, "We recognize that our clients need to ensure their clinical research plans meet International regulatory requirements especially in the US and Europe.  MDCI's extensive regulatory expertise and network of clinical research professionals in the US makes our alliance a perfect match to achieve this.  The blend of both CDSS' and MDCI's skills and infrastructure will allow us to provide all the benefits of working with a large, multinational CRO, whilst retaining the personal, tailored service that both companies pride themselves on."

About MDCI

MDCI is a full-service regulatory consulting firm and contract research organization (CRO) that helps emerging and established firms commercialize novel and innovative medical devices, in vitro diagnostics, and combination products.  Clients trust MDCI to deliver customized strategic guidance and creative "hands-on" solutions to address their unique regulatory, clinical trial, and quality assurance challenges at every stage of the product lifecycle.  MDCI has helped hundreds of clients conduct successful clinical trials, achieve regulatory clearance and approval, and maintain compliance for products in the U.S. and internationally.  By leveraging MDCI's comprehensive knowledge of FDA and international regulations, clients capture and grow market share, increase productivity, and stay competitive in an increasingly complex global marketplace.  MDCI has offices in Massachusetts and California.  Additional information is available at

About CDSS

CDSS has over 30 years experience in providing a wide range of clinical development services to medical device, pharmaceutical and biotechnology companies within the healthcare industry, specialising in Phase I to Phase IV clinical trials and in the provision of monitoring and contract research nursing services.  CDSS is the UK's leading independent research nurse provider.  Having worked with clients in the UK, Europe and the US, ranging from small start-up companies to large multinational corporations and the National Health Service (NHS), CDSS recognises the individual requirements of clients and provides a service tailored to individual needs.  By working closely with the British Consulate across the US, CDSS can help to provide information on and access to any R&D grants, funding or tax credits, which may be available.  CDSS has offices in the North of England and Massachusetts, USA.   Additional information is available at

SOURCE Medical Device Consultants, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Globus Medical Raises $110 Million in Series E Financing Round
5. Quark Pharmaceuticals Appoints New Chief Medical Officer
6. Boston University Biomedical Engineers Find Chink in Bacterias Armor
7. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
8. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
9. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
10. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
11. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
Post Your Comments:
(Date:9/27/2017)... Israel and NEW YORK , Sept. 27, ... with mobile health and big data solutions, today announced that its MyDario ... Please check your local TV listings for when The Dr. Oz Show ... ... season this month. ...
(Date:9/25/2017)... Sept. 25, 2017  EpiVax, Inc., a leader ... and immune-engineering today announced the launch of EpiVax ... of personalized therapeutic cancer vaccines. EpiVax has provided ... access to enabling technologies to the new precision ... lead EpiVax Oncology as Chief Executive Officer. Gad ...
(Date:9/22/2017)... Md. , Sept. 22, 2017  As the ... Republican Senators Bill Cassidy (R-LA) and ... Information notes that the medical device industry is in ... medical device tax, the 2.3% excise tax on medical ... But they also want covered patients, increased visits and ...
Breaking Medicine Technology:
(Date:10/12/2017)... CA (PRWEB) , ... October 12, 2017 , ... ... Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent technology. ... a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed ... consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has ... highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy ...
(Date:10/12/2017)... ... 12, 2017 , ... The American College of Medical Informatics (ACMI) will present ... the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium ... Collen, a pioneer in the field of medical informatics, this prestigious award is presented ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
(Date:10/12/2017)... Malvern, PA (PRWEB) , ... October 12, 2017 , ... ... is the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best ... New York City on October 11, 2017. , The annual award competition recognizes editorial ...
Breaking Medicine News(10 mins):